Share this article
NEW YORK, May 10, 2021 /PRNewswire/
The actinic keratosis drugs market is poised to grow by USD 709.82 million during 2021-2025, progressing at a CAGR of about 4% during the forecast period.
Technavio has announced its latest market research report titled Actinic Keratosis Drugs Market by Product and Geography - Forecast and Analysis 2021-2025
Our report talks about market scenarios, estimates, the impact of lockdown, and customer behavior.
The report on the actinic keratosis drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the high prevalence of actinic keratosis.
Bausch Health Announces Participation In Upcoming Investor Conferences yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
According to this report the market is expected to reach US$ 6,025.11 million by 2027 from US$ 4,338.61 million in 2019; it is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to the increasing diabetes prevalence and growing geriatric population. However, side-effects of gastroparesis drugs restrain the growth of the market.
On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The idiopathic type held the largest share of the market in 2019; however, the market for the diabetic type is estimated to grow at the highest CAGR during the forecast period. The rising number of research and development activities pertaining to the management of diabetic gastroparesis is estimated to offer lucrati